Alliance Pharma PLC Block Listing Six Monthly Return (8182Q)
30 June 2022 - 7:14PM
UK Regulatory
TIDMAPH
RNS Number : 8182Q
Alliance Pharma PLC
30 June 2022
For immediate release 30 June 2022
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Block Listing Six Monthly Return
Name of applicant: ALLIANCE PHARMA PLC
Names of schemes: a) The Alliance Pharma plc Approved Share Option Plan 2005
b) The Alliance Pharma plc Share Option Plan 2006
c) The Alliance Pharma plc Company Share Option Plan 2015
d) The Alliance Pharma plc Long-Term Incentive Plan 2019
---------------------------------------------------------------
Period of return: From: 28 December 2021 To: 28 June 2022
---------------------- ------------------------------ ------- ----------------------
Number of securities originally admitted at date of 25,000,000 ordinary shares of 1p each
admission: 28 June 2017
---------------------------------------------------------------
Balance of unallotted securities under schemes from a) 18,618
previous return: b) 3,091,781
c) 10,399,643
d) Nil
---------------------------------------------------------------
Plus: The amount by which the block schemes have a) 167,351
been increased since the date of the last b) Nil
return (if any increase has been applied for): c) Nil
d) 1,500,000
---------------------------------------------------------------
Less: Number of securities issued/allotted under a) 24,023
schemes during period: b) 540,613
c) 745,623
d) Nil
---------------------------------------------------------------
Equals: Balance under schemes not yet e) 161,946
issued/allotted at end of period: f) 2,551,168
g) 9,654,020
h) 1,500,000
---------------------------------------------------------------
Name of contact: Chris Chrysanthou, Company Secretary
Telephone number of contact: Tel. +44 (0)1249 705166
-------------------------------------
For further information:
Alliance Pharma plc + 44 (0)1249 466966
Cora McCallum, Head of Investor Relations
& Corporate Communications + 44 (0)1249 705168
ir@allianceph.com
+ 44 (0)20 7466
Buchanan 5000
Mark Court / Sophie Wills / Hannah Ratcliff
alliancepharma@buchanan.uk.com
+ 44 (0)20 7260
Numis Securities Limited 1000
Nominated Adviser: Freddie Barnfield / Duncan
Monteith
Corporate Broking: James Black
+ 44 (0)20 7597
Investec Bank plc 5970
Corporate Finance: Daniel Adams
Corporate Broking: Patrick Robb
About Alliance
Alliance Pharma plc (AIM: APH) is an international healthcare
group. Our purpose is to improve the lives of consumers and
patients through making available a range of clinically valuable
healthcare products.
Our core focus is on the marketing of Consumer Healthcare
brands, complemented by a smaller Prescription Medicines business.
In total, we hold marketing rights to around 80 brands, with
revenues generated from a mix of direct, distributor and e-commerce
sales.
Headquartered in the UK, Alliance employs around 250 people
based in locations across Europe, North America, and the Asia
Pacific region. By outsourcing our manufacturing and logistics
operations, we remain asset-light and focused on maximising the
value of our brands.
For more information on Alliance, please visit our website :
www.alliancepharmaceuticals.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BLRURAKRUAUNORR
(END) Dow Jones Newswires
June 30, 2022 05:14 ET (09:14 GMT)
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Apr 2024 to May 2024
Alliance Pharma (LSE:APH)
Historical Stock Chart
From May 2023 to May 2024